## BACKGROUND. Esophageal carcinoma is one of the most lethal tumors. Therefore, it is important to identify prognostic factors for patients with this disease. The objective of this study was to clarify the relation between clinicopathologic and biologic factors in esophageal carcinoma and to dete
Clinical markers of hypoxia and other predictive factors of survival in conservative therapy of squamous-cell carcinoma of the esophagus
β Scribed by Daniel Taussky; Valentin Rousson; Raoul Pescia
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 125 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0179-1958
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Squamous carcinoma of the esophagus is a disease with a poor prognosis which fortunately occurs seldom in the United States. Because patients present with more advanced disease here, surgical therapy has not equaled results reported from Asia. Although, claims of equality have appeared
Endoscopic laser therapy provides effective symptomatic palliation for patients with squamous cell carcinoma of the esophagus. To investigate whether this treatment also prolongs survival, a retrospective case-control study was performed. Ten patients with squamous cell carcinoma of the esophagus, d
## Abstract ## BACKGROUND The effects of multimodality treatment on the survival of patients with esophageal carcinoma are unclear. The authors performed a prospective, Phase II study to assess the longβterm results of chemotherapy plus radiotherapy (RT) on patients with esophageal squamous cell c
CD40 is a cell surface receptor which, when ligated, modulates apoptosis in some cell types, perhaps via activation of the expression of members of the Bcl2 gene family. This study sought to determine whether expression of CD40 in a series of 134 squamous cell carcinomas (SCCs) of the lung was relat